You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

advanced castration sensitive prostate cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Pancreatic Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8 Trial in

Recruiting
  • Advanced Pancreatic Carcinoma
  • +27 more
  • Gainesville, Florida
  • +3 more
Jan 3, 2023

Castration Resistant Prostate Cancer, Castration Sensitive Prostate Cancer Trial in Portland (drug, procedure, other)

Not yet recruiting
  • Castration Resistant Prostate Cancer
  • Castration Sensitive Prostate Cancer
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jun 16, 2023

Castration Sensitive Prostate Cancer Trial in Little Rock (Metformin, Turmeric)

Not yet recruiting
  • Castration Sensitive Prostate Cancer
  • Little Rock, Arkansas
    University of Arkansas for Medical Sciences
Sep 12, 2023

Learn About Novel Hormonal Therapies in People With Metastatic

Not yet recruiting
  • Prostatic Neoplasms
  • Novel hormonal therapy
  • New York, New York
    Pfizer Inc
Oct 2, 2023

Metastatic Castration Sensitive Prostate Cancer Trial in New York (Degarelix, Ipilimumab, Radical Prostatectomy)

Active, not recruiting
  • Metastatic Castration Sensitive Prostate Cancer
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Aug 4, 2022

Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Atlanta

Not yet recruiting
  • Castration-Sensitive Prostate Carcinoma
  • +2 more
  • Atlanta, Georgia
  • +1 more
Feb 8, 2023

Metastatic Prostate Cancer in Pirkanmaa Hospital District in

Not yet recruiting
  • Metastatic Castration Sensitive Prostate Cancer (mCSPC)
  • Metastatic Castration Resistant Prostate Cancer (mCRPC)
  • (no location specified)
Jan 17, 2023

Called AWARENESS Using Data From Alberta to Observe Treatment

Active, not recruiting
  • Metastatic Castration-sensitive Prostate Cancer
  • ADT (Eligard®*) with or without treatment intensification
  • Multiple Locations, Alberta, Canada
  • +1 more
Aug 1, 2022

Cancer Of Prostate, Prostate Tumors Trial run by the National Cancer Institute (NCI) (ADT, Prednisone, M7824)

Recruiting
  • Cancer Of Prostate
  • Prostate Neoplasms
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 6, 2022

Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Duarte

Recruiting
  • Castration-Sensitive Prostate Carcinoma
  • +4 more
  • Abiraterone Acetate
  • +7 more
  • Duarte, California
    City of Hope Medical Center
Oct 7, 2022

Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial in Oklahoma City (Sipuleucel-T)

Not yet recruiting
  • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
  • Sipuleucel-T
  • Oklahoma City, Oklahoma
    Stephenson's Cancer Center
Mar 28, 2023

Advanced Prostate Cancer Trial (HRS-5041)

Not yet recruiting
  • Advanced Prostate Cancer
  • (no location specified)
Jul 5, 2023

Prostate Adenocarcinoma Trial in Philadelphia (Niraparib Pill)

Recruiting
  • Prostate Adenocarcinoma
  • Niraparib Pill
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Mar 29, 2022

Prostate Cancer, Stage IV Prostate Cancer Trial in Tampa (Luteinizing Hormone Releasing Hormone, New Hormonal Agent, Docetaxel)

Recruiting
  • Prostate Cancer
  • Stage IV Prostate Cancer
  • Luteinizing Hormone Releasing Hormone
  • +3 more
  • Tampa, Florida
    Moffitt Cancer Center
Jun 1, 2022

Learn About Novel Hormonal Therapies for Metastatic

Not yet recruiting
  • Prostatic Neoplasms
  • Novel hormonal therapy
  • New York, New York
    Pfizer Inc
Nov 21, 2023

Prostate Cancer Trial (Dutasteride, Abiraterone)

Not yet recruiting
  • Prostate Cancer
  • (no location specified)
Jan 30, 2023

Metastatic Hormone-Sensitive Prostate Cancer Trial (Rezvilutamide, Rezvilutamide plus abiraterone, Continue previous treatment)

Not yet recruiting
  • Metastatic Hormone-Sensitive Prostate Cancer
  • (no location specified)
Nov 10, 2023

Prostate Cancer, Prostate Tumors, Tumors, Prostatic Trial run by the NCI (PROSTVAC-V, PROSTVAC-F, Docetaxel)

Active, not recruiting
  • Prostate Cancer
  • +2 more
  • PROSTVAC-V
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jan 14, 2022

Prostatic Tumors, Metastatic Castration-Resistant Prostate Cancer Trial (MK-5684, Dexamethasone, Fludrocortisone acetate)

Not yet recruiting
  • Prostatic Neoplasms
  • Metastatic Castration-Resistant Prostate Cancer
  • (no location specified)
Oct 23, 2023

Oligometastatic Hormone Sensitive Prostate Cancer Trial in Florence (SBRT on all sites of metastatic disease+Apalutamide)

Not yet recruiting
  • Oligometastatic Hormone Sensitive Prostate Cancer
  • SBRT on all sites of metastatic disease+Apalutamide
  • Florence, Italy
    AOU Careggi Radiation Oncology Unit
Jan 29, 2023

Castration-Resistant Prostatic Cancer Trial ([Lu-177]-PNT2002)

Available
  • Castration-Resistant Prostatic Cancer
  • (no location specified)
Sep 11, 2023

Metastatic Castration-resistant Prostate Cancer Trial in Mexico City (SV-102)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Mexico City, Mexico
    Hospital Diomed
Sep 14, 2022

Prostatic Tumors, Metastatic Castration-Resistant Prostate Cancer Trial (MK-5684, Dexamethasone, Fludrocortisone)

Not yet recruiting
  • Prostatic Neoplasms
  • Metastatic Castration-Resistant Prostate Cancer
  • (no location specified)
Nov 13, 2023

Metastatic Castrate-sensitive Prostate Cancer Trial in Germany, United States (Apalutamide, Androgen-deprivation Therapy (ADT))

Not yet recruiting
  • Metastatic Castrate-sensitive Prostate Cancer
  • Lakewood, Colorado
  • +5 more
May 23, 2023

Metastatic Castration-resistant Prostate Cancer Trial in Salt Lake City (Bortezomib)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Salt Lake City, Utah
    Huntsman Cancer Institute/University of Utah
Sep 7, 2023